The Best Nuclear Energy Stocks to Buy and Hold for Decades

The article is bullish on nuclear power stocks, highlighting AI-driven electricity demand, U.S. policy support for quadrupling nuclear capacity by 2050, and the role of small modular reactors in future power generation. Oklo is described as a higher-risk, pre-revenue developer with $1.6 billion in cash and a $33 million first-quarter net loss, while NuScale has NRC approval for two SMR designs and a potential 6-gigawatt TVA project. Overall, it frames both names as long-duration growth opportunities, though with significant regulatory and execution risk.

Analysis

The market is treating nuclear as a single trade, but the cleaner expression is a bifurcation between permitting optionality and monetization certainty. SMR is the higher-quality regulatory asset: approval de-risks the design itself, which should matter more as utilities increasingly need bankable baseload to support AI load growth and grid resiliency. OKLO remains the more speculative torque name because its value is still mostly a claim on future licensing and project execution; that makes it more sensitive to any delay in NRC timelines, capital market appetite, or project slippage than to the broader nuclear theme.

Second-order, the likely winner is not necessarily the reactor OEMs but the ecosystem around them: grid equipment, cooling, fuel-cycle services, and power-hungry hyperscalers that can pre-contract capacity. If AI data-center buildouts keep accelerating, utilities will face a capacity bottleneck before they face a technology-choice bottleneck, which favors firms able to sign long-duration capacity deals and secure financing. That dynamic is more supportive of SMR’s utility-facing model than OKLO’s point-solution narrative, while also increasing the odds that partners and suppliers to the nuclear buildout re-rate before first revenue at the reactor names.

The contrarian risk is that investors are underestimating how long the path from approval to cash flow can remain. Even with favorable policy, nuclear projects have a habit of turning into execution stories rather than category growth stories; the near-term multiple expansion can outrun fundamental progress by multiple quarters. If risk appetite fades or rates back up, the long-duration cash burn in OKLO becomes the weak link first, while SMR likely holds up better because approval creates more credible downstream optionality.

Meta is a subtle beneficiary: any credible off-grid or behind-the-meter power solution lowers the risk that AI expansion becomes constrained by utility interconnection delays. NVDA is not a direct winner from nuclear economics, but faster AI capex only matters if power availability stops being the gating item; that makes nuclear an enabling theme rather than a semiconductor substitute. NFLX has no meaningful first-order exposure here.

Key Decisions for Investors

• Go long SMR vs. OKLO as a 3-6 month relative-value pair: SMR has the cleaner regulatory moat and better utility-fit, while OKLO remains a higher-beta licensing story; target 20-30% relative outperformance if nuclear enthusiasm broadens but execution remains the key filter.
• Initiate a small tactical long in OKLO only on pullbacks after licensing-related volatility, not strength; use it as an event-driven optionality trade with a hard stop if NRC cadence slips, since the downside is dominated by timeline extension rather than demand.
• Add META on any AI-power pullback over 1-3 months: more credible distributed power solutions lower the probability that data-center expansion hits infrastructure bottlenecks, which should support capex durability and preserve upside to AI-driven ad and cloud monetization.
• For more conservative exposure, buy a basket of nuclear-adjacent infrastructure suppliers rather than the reactor names on a 6-12 month horizon; the risk/reward is better because revenue arrives earlier and is less binary than commercial reactor adoption.
• Avoid chasing NVDA/NFLX as nuclear proxies; if anything, only pair them synthetically against high-duration nuclear equities when rates rise, since the market is likely to overprice the nuclear growth story before the first meaningful cash flows appear.